Mild side effects (as outlined below) have been reported among ustekinumab users. Major side effects such as serious infections and major adverse cardiovascular events are rare. The adverse event profile is similar between psoriasis and psoriatic arthritis patients. However, abdominal pain, fever, and diarrhea have been reported for maintenance doses of ustekinumab for Chrohn and ulcerative colitis patients.

The following adverse effects have been reported:

**Serious Reactions**

- Severe infections or exacerbation/reactivation of existing infection (bacterial, mycobacterial, fungal, viral)

- Malignancy (e.g., non-melanoma skin cancer)

- Hypersensitivity reactions/anaphylaxis

- Reversible posterior leukoencephalopathy syndrome

- Cryptogenic organizing pneumonia

- Interstitial or eosinophilic pneumonia

**Common Reactions**

- Nasopharyngitis

- Headache

- Fatigue

- Vomiting after induction in inflammatory bowel disease

- Injection site erythema

- Bronchitis/upper respiratory tract infection

- Sinusitis

- Abdominal pain, fever, influenza, and diarrhea while used for maintenance therapy in inflammatory bowel disease

- Back pain

**Other Reported Reactions**

- Pruritus

- Pustular and erythrodermic psoriasis

- Exfoliative dermatitis

Ustekinumab has been generally well tolerated by patients in clinical trials, with most adverse events being mild in severity.